← back to search

Daniel Stadlbauer

National Influenza Center · US
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Influenza Virus Research Studies, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, and Respiratory viral infections research.
h-index
36
citations
10,055
works
85
NIH funding
primary concept
Medicine
email

Recent publications

Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates
Cell 2024cited by 94position: middledoi
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
New England Journal of Medicine 2021cited by 802position: middledoi
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
The Lancet Microbe 2021cited by 435position: middledoi
Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers
The Journal of Infectious Diseases 2021cited by 84position: middledoi
Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial
npj Vaccines 2021cited by 32position: middledoi
A serological assay to detect SARS-CoV-2 seroconversion in humans
Nature Medicine 2020cited by 1,965position: middledoi
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Science 2020cited by 1,261position: middledoi
SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup
Current Protocols in Microbiology 2020cited by 810position: firstdoi
Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
Nature Medicine 2020cited by 501position: middledoi
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Nature Medicine 2020cited by 355position: middledoi
Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans
Proceedings of the National Academy of Sciences 2020cited by 87position: middledoi
Broadly protective human antibodies that target the active site of influenza virus neuraminidase
Science 2019cited by 282position: firstdoi
Characterization of swine-origin H1N1 canine influenza viruses
Emerging Microbes & Infections 2019cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Florian Krammer · Semmelweis University6 papers (2019–2021)Meagan McMahon · CSL Seqirus Ltd3 papers (2019–2020)Fatima Amanat · Icahn School of Medicine at Mount Sinai3 papers (2020–2021)Viviana Simon · Stanford University3 papers (2019–2020)Shirin Strohmeier · BOKU University3 papers (2019–2020)Philip Meade · DIPF | Leibniz Institute for Research and Information in Education2 papers (2020–2020)Kaijun Jiang · Mississippi State University2 papers (2020–2021)Esther Dawen Yu · La Jolla Institute for Immunology1 papers (2021–2021)Stephen A. Rawlings · MaineHealth1 papers (2021–2021)Jennifer M. Dan · University of California System1 papers (2021–2021)José Mateus · Pontificia Universidad Javeriana1 papers (2021–2021)Jackson S. Turner · University School1 papers (2019–2019)Mark J. Mulligan · NYU Langone Health1 papers (2021–2021)Jesse O’Shea · Centers for Disease Control and Prevention1 papers (2021–2021)Xueyong Zhu · Scripps Research Institute1 papers (2019–2019)Damodara Rao Mendu · Mount Sinai Hospital1 papers (2020–2020)Christina Capuano · Icahn School of Medicine at Mount Sinai1 papers (2020–2020) · 1 papers (2021–2021)Daniela Weiskopf · La Jolla Institute for Immunology1 papers (2021–2021) · 1 papers (2019–2019)